JP2011501958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011501958A5 JP2011501958A5 JP2010532042A JP2010532042A JP2011501958A5 JP 2011501958 A5 JP2011501958 A5 JP 2011501958A5 JP 2010532042 A JP2010532042 A JP 2010532042A JP 2010532042 A JP2010532042 A JP 2010532042A JP 2011501958 A5 JP2011501958 A5 JP 2011501958A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- sign
- cell
- cells
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80007P | 2007-10-29 | 2007-10-29 | |
| PCT/US2008/012251 WO2009058285A2 (en) | 2007-10-29 | 2008-10-29 | PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011501958A JP2011501958A (ja) | 2011-01-20 |
| JP2011501958A5 true JP2011501958A5 (https=) | 2011-12-15 |
Family
ID=40591693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532042A Pending JP2011501958A (ja) | 2007-10-29 | 2008-10-29 | ブタＤＣ−ＳＩＧＮ、ＩＣＡＭ−３およびＬＳＥＣｔｉｎならびにそれらの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8415118B2 (https=) |
| EP (2) | EP2662384A1 (https=) |
| JP (1) | JP2011501958A (https=) |
| KR (1) | KR20100087344A (https=) |
| CN (1) | CN102066415A (https=) |
| AU (1) | AU2008319384A1 (https=) |
| BR (1) | BRPI0818477A2 (https=) |
| CA (1) | CA2704207A1 (https=) |
| CO (1) | CO6270367A2 (https=) |
| MX (1) | MX2010004548A (https=) |
| NZ (1) | NZ584893A (https=) |
| RU (1) | RU2010121862A (https=) |
| WO (1) | WO2009058285A2 (https=) |
| ZA (1) | ZA201002773B (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102947341B (zh) | 2010-01-19 | 2018-07-06 | 哈佛大学校长及研究员协会 | 用于病原体检测和治疗的工程化调理素 |
| WO2013012924A2 (en) | 2011-07-18 | 2013-01-24 | President And Fellows Of Harvard College | Engineered microbe-targeting molecules and uses thereof |
| WO2013090806A2 (en) | 2011-12-15 | 2013-06-20 | Washington University | Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection |
| CN104284984B (zh) | 2012-02-29 | 2017-10-13 | 哈佛大学校长及研究员协会 | 抗生素药敏性的快速测试 |
| JP6254146B2 (ja) | 2012-03-27 | 2017-12-27 | エヌジーエム バイオファーマシューティカルス，インコーポレーテッド | 代謝障害を治療するための組成物および方法 |
| EP2976642A4 (en) | 2013-03-15 | 2016-09-21 | Harvard College | METHOD AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR RECORDING OF A TARGET UNIT |
| WO2014190040A1 (en) | 2013-05-21 | 2014-11-27 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof |
| EP3083658B1 (en) | 2013-12-18 | 2019-05-08 | President and Fellows of Harvard College | Crp capture/detection of gram positive bacteria |
| MX370115B (es) | 2014-07-30 | 2019-12-02 | Ngm Biopharmaceuticals Inc | Dímeros que comprenden dos polipéptidos, útiles en el tratamiento de trastornos metabólicos. |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| PL3212226T3 (pl) | 2014-10-31 | 2020-11-02 | Ngm Biopharmaceuticals, Inc. | Kompozycje i sposoby stosowania w leczeniu zaburzeń metabolicznych |
| CN104749361B (zh) * | 2015-01-21 | 2017-04-19 | 中国农业科学院哈尔滨兽医研究所 | 猪圆环病毒2型抗原捕获elisa试剂盒 |
| CN105445457B (zh) * | 2015-03-24 | 2017-08-11 | 中国农业科学院哈尔滨兽医研究所 | 检测猪圆环病毒2型Cap蛋白的单克隆抗体及试剂盒 |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US10435457B2 (en) | 2015-08-06 | 2019-10-08 | President And Fellows Of Harvard College | Microbe-binding molecules and uses thereof |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CN106957847A (zh) * | 2017-05-16 | 2017-07-18 | 吉林大学 | 有效抑制仔猪流行性腹泻病毒的siRNA及用途 |
| CN107488635A (zh) * | 2017-09-22 | 2017-12-19 | 中国人民解放军第三军医大学第三附属医院 | 单克隆细胞及其制备方法和用途 |
| CN108893474B (zh) * | 2018-02-07 | 2021-11-16 | 电子科技大学 | 草鱼细胞间粘附分子基因的分离和鉴定 |
| CN108977444A (zh) * | 2018-06-28 | 2018-12-11 | 西南大学 | 沉默荣昌猪CD14表达的siRNA及筛选方法与应用 |
| CN109679952B (zh) * | 2018-12-24 | 2022-04-15 | 西北农林科技大学 | 一种抗PRRSV感染的猪源miR-c89及其应用 |
| CN109652384B (zh) * | 2019-02-21 | 2021-10-26 | 昆明理工大学 | 一种体外培养戊型肝炎病毒的方法 |
| CN109836478B (zh) * | 2019-03-19 | 2022-06-14 | 扬州大学 | 非洲猪瘟病毒p11.5蛋白特异性多克隆抗体的制备方法及应用 |
| CN109943536B (zh) * | 2019-03-26 | 2021-09-14 | 昆明理工大学 | 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法 |
| CN111575409B (zh) * | 2020-05-23 | 2023-04-18 | 黑龙江八一农垦大学 | 基于整合素配体识别肽抑制猪流行性腹泻病毒感染的研究方法 |
| WO2022050476A1 (ko) * | 2020-09-04 | 2022-03-10 | 이형우 | 인간 면역결핍 바이러스 감염 또는 감염 질환의 치료용 조성물 |
| CN115725656B (zh) * | 2021-09-01 | 2026-01-16 | 联邦生物科技(珠海横琴)有限公司 | 一种以细胞质rna病毒为载体递送干扰rna的方法 |
| CN121454060A (zh) * | 2026-01-05 | 2026-02-03 | 江苏立维斯德生物技术有限公司 | 一种基于免疫荧光法检测轮状病毒的方法、试剂盒及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2137547A1 (en) * | 1992-06-11 | 1993-12-23 | Daniel Meruelo | Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| GB9409768D0 (en) | 1994-05-16 | 1994-07-06 | Medical Res Council | Trimerising polypeptides |
| US6146873A (en) | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
| US6280953B1 (en) | 1998-01-30 | 2001-08-28 | Evolutionary Genomics, L.L.C. | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| JP2002543762A (ja) * | 1999-03-25 | 2002-12-24 | ブリストル−マイヤーズ スクイブ カンパニー | ヒトｃｌａｘタンパク質およびその可溶性融合タンパク質をコードするｄｎａ分子 |
| US6365156B1 (en) | 1999-04-16 | 2002-04-02 | Osel, Inc. | Method for improving the half-life of soluble viral-specific ligands on mucosal membranes |
| EP1046651A1 (en) | 1999-04-19 | 2000-10-25 | Koninklijke Universiteit Nijmegen | Composition and method for modulating dendritic cell-T interaction |
| US6391567B1 (en) | 2000-03-02 | 2002-05-21 | New York University | Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
| GB0318247D0 (en) * | 2003-08-05 | 2003-09-10 | Royal Veterinary College | Antigen delivery system |
| BRPI0508762A (pt) | 2004-04-16 | 2007-08-14 | Genentech Inc | método de aumento do esgotamento de células b em mamìferos, método de aumento da eficácia do esgotamento de células b, método de tratamento de malignidade ou neoplasma de células b, método de alìvio de disfunção autoimunológica regulada por células b, método de esgotamento das células b e composição |
-
2008
- 2008-10-29 JP JP2010532042A patent/JP2011501958A/ja active Pending
- 2008-10-29 NZ NZ584893A patent/NZ584893A/xx not_active IP Right Cessation
- 2008-10-29 WO PCT/US2008/012251 patent/WO2009058285A2/en not_active Ceased
- 2008-10-29 BR BRPI0818477 patent/BRPI0818477A2/pt not_active IP Right Cessation
- 2008-10-29 CA CA2704207A patent/CA2704207A1/en not_active Abandoned
- 2008-10-29 RU RU2010121862/10A patent/RU2010121862A/ru not_active Application Discontinuation
- 2008-10-29 EP EP13179857.1A patent/EP2662384A1/en not_active Withdrawn
- 2008-10-29 US US12/739,744 patent/US8415118B2/en not_active Expired - Fee Related
- 2008-10-29 AU AU2008319384A patent/AU2008319384A1/en not_active Abandoned
- 2008-10-29 CN CN2008801240560A patent/CN102066415A/zh active Pending
- 2008-10-29 KR KR1020107011603A patent/KR20100087344A/ko not_active Withdrawn
- 2008-10-29 EP EP08844649A patent/EP2207798A2/en not_active Withdrawn
- 2008-10-29 MX MX2010004548A patent/MX2010004548A/es active IP Right Grant
-
2010
- 2010-04-20 ZA ZA2010/02773A patent/ZA201002773B/en unknown
- 2010-04-29 CO CO10050942A patent/CO6270367A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011501958A5 (https=) | ||
| Burleigh et al. | Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes | |
| Peeters et al. | Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence | |
| Iwatsuki-Horimoto et al. | Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence | |
| Fodor et al. | Rescue of influenza A virus from recombinant DNA | |
| Tatsuo et al. | Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors | |
| Iwatsuki-Horimoto et al. | The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly | |
| Moll et al. | Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses | |
| Schmitt et al. | Requirements for budding of paramyxovirus simian virus 5 virus-like particles | |
| Seki et al. | Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells | |
| CN101379183B (zh) | 流感病毒的拯救 | |
| Shi et al. | Mapping the Golgi targeting and retention signal of Bunyamwera virus glycoproteins | |
| Howitt et al. | Adenovirus interaction with its cellular receptor CAR | |
| de Wit et al. | A reverse-genetics system for Influenza A virus using T7 RNA polymerase | |
| RU2010121862A (ru) | DC-SIGN, ICAM-3 И LSECtin СВИНЬИ И ИХ ПРИМЕНЕНИЯ | |
| Kim et al. | Expression and stability of foreign tags inserted into nsp2 of porcine reproductive and respiratory syndrome virus (PRRSV) | |
| JP2019500051A5 (https=) | ||
| Neumann et al. | Generation of influenza A virus from cloned cDNAs—historical perspective and outlook for the new millenium | |
| Eifan et al. | Mutational analysis of the Bunyamwera orthobunyavirus nucleocapsid protein gene | |
| Shi et al. | Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein | |
| Yan et al. | Production of transgenic pigs over-expressing the antiviral gene Mx1 | |
| Muraki et al. | A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein | |
| Seth et al. | Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion | |
| Tsurudome et al. | Identification of regions on the fusion protein of human parainfluenza virus type 2 which are required for haemagglutinin-neuraminidase proteins to promote cell fusion | |
| Wagner et al. | Rescue of recombinant Thogoto virus from cloned cDNA |